An effect of fasting insulin on endometrial cancer risk was also strongly attenuated upon adjustment for bioavailable testosterone levels which could reflect mediation of this effect by bioavailable testosterone or conditionally weak instrument bias for fasting insulin concentrations in this analysis. This evidence concerns the gene INS and endometrial cancer.